A pairing appears on this page only when a trial gave both ingredients together and measured the result. Capers has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
The flavonol in caper buds is present largely as glycosides including rutin, which are hydrolysed by gut enzymes and colonic bacteria to release the quercetin aglycone before absorption. So caper is a food delivery route for the same compound sold as an isolate. The glycoside form changes absorption kinetics compared with pure aglycone. Anyone taking both is stacking one compound, not combining two.
Rutin resists small-intestinal hydrolysis because of its rhamnose-glucose disaccharide and reaches the colon, where bacterial rhamnosidases release quercetin for absorption. This shifts and delays the appearance of metabolites compared with glucoside forms. It is the reason two flavonol products with identical total quercetin can behave differently. The chemistry is well established; the practical consequences vary between people by microbiome.
Ascorbate reduces flavonoid radicals back to the parent phenol, extending the antioxidant pool in solution, and flavonols in turn slow ascorbate oxidation in the presence of transition metals. This is solution chemistry that also matters for product stability. It is not a demonstrated clinical combination. The pairing describes what happens in the preparation more reliably than what happens in a person.
The catechol B-ring of quercetin binds ferric iron and forms complexes that are not absorbed, which lowers uptake of non-heme iron eaten in the same meal. Caper buds are eaten in small quantities, so the meal-level effect is likely small, but a concentrated caper extract taken with an iron supplement is a different proposition. Spacing the two by a couple of hours avoids the overlap. Established polyphenol-iron chemistry.
Salt-packed and brined capers are preserved by sodium chloride, so the culinary ingredient contributes meaningfully to sodium intake for its weight. Rinsing removes a good part of the surface salt but not what has penetrated the bud. This matters for anyone counting sodium, and it does not apply to a dried extract where the preservation salt has been removed. Flagging the additive direction is the point here.
Caper glucosinolate is hydrolysed by myrosinase to methyl isothiocyanate, part of the same isothiocyanate chemistry that produces sulforaphane in broccoli. Both are electrophiles that engage the Nrf2-Keap1 signalling axis. The isothiocyanates differ in potency and in which tissues they reach. This is shared chemistry at the class level, not equivalence between the two compounds.
Piperine inhibits intestinal and hepatic UDP-glucuronosyltransferases and CYP3A4, which slows first-pass conjugation of quercetin and raises measured plasma concentrations. The same inhibition applies to any co-administered drug cleared by those routes, which is the reason to take the pairing seriously rather than casually. The kinetic effect is documented for several polyphenols; whether it improves any outcome is separate. Read it as a pharmacokinetic tool with an interaction caution attached.
Lactase-phlorizin hydrolase at the brush border and cytosolic beta-glucosidase deglycosylate flavonol glucosides, while rutinosides need bacterial rhamnosidase. Enzyme preparations containing rhamnosidase or naringinase could in principle release aglycone earlier in the tract. Whether commercially available digestive enzyme blends do this to a meaningful degree has not been shown. The mechanism is sound, the application is speculative.
Nothing specific on file for Capers. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Capers. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.